MedTrace Logo

ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"

NCT05309707 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-04-04

No results posted yet for this study

Summary

The ENDOBARC-S post-market clinical follow-up study is undertaken to evaluate the prevention of death related to aortic arch pathologies when treated by branch stent graft systems (Nexus stent-graft system®, Relay Branch® or Zenith arch branch graft®), with proximal landing at zone 0.

The secondary objective is to evaluate the safety and clinical performance of the studied devices.

Conditions

  • Thoracic Aortic Aneurysm
  • Thoracic Aortic Dissection
  • Stent-Graft Endoleak
  • Stent-Graft Stenosis
  • Intramural Hematoma
  • Aortic Diseases
  • Cardiovascular Diseases
  • Vascular Diseases

Interventions

DEVICE

Endovascular exclusion

Endovascular exclusion by branch stent graft systems (Nexus stent-graft system®, Relay Branch® or Zenith arch branch graft®), with proximal landing at zone 0.

Sponsors & Collaborators

  • Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-01-01
Completion
2027-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309707 on ClinicalTrials.gov